150 related articles for article (PubMed ID: 28432481)
1. The Pretreatment Neutrophil-to-Lymphocyte Ratio is a Prognostic Determinant of T3-4 Hypopharyngeal Squamous Cell Carcinoma.
Lo WC; Wu CT; Wang CP; Yang TL; Lou PJ; Ko JY; Chang YL
Ann Surg Oncol; 2017 Jul; 24(7):1980-1988. PubMed ID: 28432481
[TBL] [Abstract][Full Text] [Related]
2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Lymph Node Density in Patients with Hypopharyngeal Squamous Cell Carcinoma.
Joo YH; Cho KJ; Kim SY; Kim MS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1014-9. PubMed ID: 26178762
[TBL] [Abstract][Full Text] [Related]
4. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
5. Lymph Node Ratio Predicts Recurrence and Survival for Patients with Resectable Stage 4 Hypopharyngeal Cancer.
Lo WC; Wu CT; Wang CP; Yang TL; Lou PJ; Ko JY; Chang YL
Ann Surg Oncol; 2017 Jun; 24(6):1707-1713. PubMed ID: 28130622
[TBL] [Abstract][Full Text] [Related]
6. Patterns of regional lymph node failure of locally advanced hypopharyngeal squamous cell carcinoma after first-line treatment with surgery and/or intensity-modulated radiotherapy.
Wang D; Yu S; Zhai L; Xu J; Li B
BMC Cancer; 2020 Apr; 20(1):283. PubMed ID: 32252691
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
[TBL] [Abstract][Full Text] [Related]
10. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer.
Kim SY; Rho YS; Choi EC; Kim MS; Woo JH; Lee DH; Chung EJ; Park MW; Kim DH; Joo YH
BMC Cancer; 2017 Dec; 17(1):904. PubMed ID: 29284434
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
[TBL] [Abstract][Full Text] [Related]
13. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx.
Brasilino de Carvalho M
Head Neck; 1998 Jan; 20(1):16-21. PubMed ID: 9464947
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
Wang J; Kalhor N; Hu J; Wang B; Chu H; Zhang B; Guan Y; Wu Y
PLoS One; 2016; 11(10):e0163397. PubMed ID: 27695079
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
Ock CY; Nam AR; Lee J; Bang JH; Lee KH; Han SW; Kim TY; Im SA; Kim TY; Bang YJ; Oh DY
Gastric Cancer; 2017 Mar; 20(2):254-262. PubMed ID: 27147244
[TBL] [Abstract][Full Text] [Related]
17. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
[TBL] [Abstract][Full Text] [Related]
18. The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma.
Chen MF; Chen PT; Kuan FC; Chen WC
Ann Surg Oncol; 2019 Jan; 26(1):190-199. PubMed ID: 30362062
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-to-lymphocyte ratio as prognostic predictor for hypopharyngeal squamous cell carcinoma after radical resections.
Song Y; Liu H; Gao L; Liu X; Ma L; Lu M; Gao Z
J Craniofac Surg; 2015 Mar; 26(2):e137-40. PubMed ID: 25643330
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
